(Total Views: 367)
Posted On: 07/11/2022 11:45:52 AM
Post# of 16

$RHHBY News Article - New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile of Genentech's Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A https://marketwirenews.com/news-releases/new-...82436.html


My Twitter: WhyteStocks